India · Delayed Price · Currency is INR Anthem Biosciences Statistics
Total Valuation
NSE:ANTHEM has a market cap or net worth of INR 430.28 billion. The enterprise value is 421.43 billion.
| Market Cap | 430.28B |
| Enterprise Value | 421.43B |
Important Dates
The next estimated earnings date is Wednesday, June 24, 2026.
| Earnings Date | Jun 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ANTHEM has 561.61 million shares outstanding. The number of shares has increased by 1.04% in one year.
| Current Share Class | 561.61M |
| Shares Outstanding | 561.61M |
| Shares Change (YoY) | +1.04% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 80.41% |
| Owned by Institutions (%) | 10.64% |
| Float | 61.92M |
Valuation Ratios
The trailing PE ratio is 73.46 and the forward PE ratio is 59.27. NSE:ANTHEM's PEG ratio is 2.47.
| PE Ratio | 73.46 |
| Forward PE | 59.27 |
| PS Ratio | 20.25 |
| PB Ratio | 14.14 |
| P/TBV Ratio | 14.14 |
| P/FCF Ratio | 67.94 |
| P/OCF Ratio | 50.95 |
| PEG Ratio | 2.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.54, with an EV/FCF ratio of 66.54.
| EV / Earnings | 71.21 |
| EV / Sales | 19.84 |
| EV / EBITDA | 50.54 |
| EV / EBIT | 60.23 |
| EV / FCF | 66.54 |
Financial Position
The company has a current ratio of 5.54, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.54 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.09 |
| Interest Coverage | 101.50 |
Financial Efficiency
Return on equity (ROE) is 21.71% and return on invested capital (ROIC) is 25.20%.
| Return on Equity (ROE) | 21.71% |
| Return on Assets (ROA) | 14.02% |
| Return on Invested Capital (ROIC) | 25.20% |
| Return on Capital Employed (ROCE) | 22.55% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 10.82M |
| Profits Per Employee | 3.01M |
| Employee Count | 1,963 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.49 |
Taxes
In the past 12 months, NSE:ANTHEM has paid 2.32 billion in taxes.
| Income Tax | 2.32B |
| Effective Tax Rate | 28.20% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 766.85 |
| 200-Day Moving Average | 712.05 |
| Relative Strength Index (RSI) | 53.39 |
| Average Volume (20 Days) | 583,598 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ANTHEM had revenue of INR 21.24 billion and earned 5.92 billion in profits. Earnings per share was 10.43.
| Revenue | 21.24B |
| Gross Profit | 13.12B |
| Operating Income | 7.00B |
| Pretax Income | 8.24B |
| Net Income | 5.92B |
| EBITDA | 8.34B |
| EBIT | 7.00B |
| Earnings Per Share (EPS) | 10.43 |
Balance Sheet
The company has 9.40 billion in cash and 539.24 million in debt, with a net cash position of 8.87 billion or 15.79 per share.
| Cash & Cash Equivalents | 9.40B |
| Total Debt | 539.24M |
| Net Cash | 8.87B |
| Net Cash Per Share | 15.79 |
| Equity (Book Value) | 30.43B |
| Book Value Per Share | 54.19 |
| Working Capital | 14.77B |
Cash Flow
In the last 12 months, operating cash flow was 8.44 billion and capital expenditures -2.11 billion, giving a free cash flow of 6.33 billion.
| Operating Cash Flow | 8.44B |
| Capital Expenditures | -2.11B |
| Depreciation & Amortization | 1.34B |
| Net Borrowing | -593.93M |
| Free Cash Flow | 6.33B |
| FCF Per Share | 11.28 |
Margins
Gross margin is 61.76%, with operating and profit margins of 32.94% and 27.86%.
| Gross Margin | 61.76% |
| Operating Margin | 32.94% |
| Pretax Margin | 38.80% |
| Profit Margin | 27.86% |
| EBITDA Margin | 39.25% |
| EBIT Margin | 32.94% |
| FCF Margin | 29.81% |
Dividends & Yields
NSE:ANTHEM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.04% |
| Shareholder Yield | -1.04% |
| Earnings Yield | 1.38% |
| FCF Yield | 1.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ANTHEM is 879.43, which is 13.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 879.43 |
| Price Target Difference | 13.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 19.35% |
| EPS Growth Forecast (3Y) | 22.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |